Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex
Serological cross-reactivity providing cross-protective immunity between antigenically related viruses is a cornerstone of vaccination. It was the immunological basis for the first human vaccine against smallpox introduced more than 200 years ago, and continues to underpin modern vaccine development as has recently been shown for human papillomavirus vaccines, which confer cross-protection against other oncogenic papillomavirus types not present in the vaccine. Here, we review the feasibility...[Show more]
|Collections||ANU Research Publications|
|Source:||Expert Review of Vaccines|
|01_Lobigs_Feasibility_of_2012.pdf||727.01 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.